All the news Showing 10 of 733 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Screening policy 30 million screened for hepatitis C in four months in Egypt Keith Alcorn / 11 April 2019 Egypt screened almost 30 million people for hepatitis C in the first four months of a national screening programme that kicked off in October 2018, Egyptian researchers announced at The International Liver Congress ... Screening policy Same-day hepatitis C treatment initiation can be achieved at large scale, Egyptian pilot study shows Keith Alcorn / 11 April 2019 Screening for hepatitis C, confirmation of chronic infection by point-of-care viral load testing and treatment initiation can all be achieved on the same day in a community setting, Egyptian researchers reported at The ... Hepatitis B Global drive for hepatitis B cure launched at International Liver Congress Keith Alcorn / 10 April 2019 The Global Scientific Strategy to Cure Hepatitis B (The ICE-HBV Strategy) by the International Coalition to Eliminate HBV (ICE-HBV), a global group of researchers, patient representatives and health organisations, was released on the opening ... Screening and testing policy Is opt-out testing for HCV improving testing rates in UK prisons? Keith Alcorn / 04 April 2019 Testing rates for hepatitis C virus (HCV) in prisons in the United Kingdom remain far below the national minimum target of 50% and without radical change, prison testing rates will pose a ... Sexual transmission Epidemic of sexually transmitted hepatitis C in gay men now involves both HIV-positive and HIV-negative men Michael Carter / 29 March 2019 Incidence of acute hepatitis C virus (HCV) among men who have sex with men (MSM) who use pre-exposure prophylaxis (PrEP) in Lyon increased tenfold between 2016 and 2017, according to ... Hepatocellular carcinoma (HCC) Epigenetic changes persist after hepatitis C cure in liver cells, may predict liver cancer Keith Alcorn / 26 March 2019 Hepatitis C infection leaves permanent changes in the activity of genes in the liver even after the infection is cured and these changes are associated with an increased risk of liver cancer, ... Treatment outcomes Hepatitis C treatment appears safe and effective for pregnant women Liz Highleyman / 20 March 2019 Treatment with sofosbuvir/ledipasvir (Harvoni) was well tolerated and cured all pregnant women with hepatitis C virus (HCV), according to a study presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2019) ... Diabetes & HCV Hepatitis C treatment reduces risk of diabetes Liz Highleyman / 18 March 2019 Treatment of hepatitis C virus (HCV) infection is associated with better glucose control and a lower likelihood of developing diabetes, according to a report at the Conference on Retroviruses and Opportunistic Infections (CROI ... Hepatocellular carcinoma (HCC) Higher HIV viral load and lower CD4 count linked to liver cancer risk Liz Highleyman / 14 March 2019 People living with HIV who have a longer duration of detectable viral load and those with low CD4 cell counts have a higher likelihood of developing liver cancer in the absence of ... Treatment for people who use drugs HCV reinfection in people who inject drugs a sign of a successful treatment programme, say researchers Keith Alcorn / 11 March 2019 High rates of reinfection in people who inject drugs are a sign that access to treatment is improving, not a sign of failure, and should prompt retreatment, not stigmatisation, Australian hepatitis researcher ... ← Prev12345...74Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds